ROYAL BANK OF CANADA - MELINTA THERAPEUTICS INC ownership

MELINTA THERAPEUTICS INC's ticker is MLNTXXXX and the CUSIP is 58549G100. A total of 89 filers reported holding MELINTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.7%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MELINTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$0
-100.0%
35
-95.5%
0.00%
Q3 2018$3,000
+200.0%
775
+400.0%
0.00%
Q2 2018$1,000155
+474.1%
0.00%
Q1 2018$0
-100.0%
27
-95.7%
0.00%
Q4 2017$10,0006330.00%
Other shareholders
MELINTA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
OIKOS HOLDINGS LLC 16,607,959$105,461,00064.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,995,806$25,373,0000.89%
SPHERA FUNDS MANAGEMENT LTD. 984,492$6,252,0000.86%
Virtus ETF Advisers LLC 96,866$615,0000.54%
Monashee Investment Management LLC 394,600$2,506,0000.48%
Eversept Partners, LP 76,837$487,9150.22%
Stonepine Capital Management, LLC 52,200$331,0000.20%
Granahan Investment Management 304,191$1,932,0000.12%
Fiduciary Trust Co International of Pennsylvania 265,727$1,687,0000.08%
BOENNING & SCATTERGOOD, INC. 23,750$151,0000.05%
View complete list of MELINTA THERAPEUTICS INC shareholders